BURLINGTON, Mass., June 4, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Wells Fargo Securities 2013 Healthcare Conference at the Intercontinental Hotel in Boston, MA. George W. LeMaitre, Chairman and CEO, will provide an update on the Company on Wednesday, June 19, 2013 at 10:40 am EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart, including the 1.5mm Expandable LeMaitre® Valvulotome, MultiTASCTM Dissection/Transection Device, and XenoSure® Vascular Patch. Additional information can be found at http://www.lemaitre.com.